Jaipur: Limited viral load testing capabilities are causing delays in treating hepatitis patients. The health department struggles to conduct viral load tests for about 45% of diagnosed hepatitis C ...
Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already.